Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

29.21
+0.47001.64%
Post-market: 29.210.00000.00%18:52 EST
Volume:1.09M
Turnover:31.17M
Market Cap:1.63B
PE:-18.99
High:29.43
Open:28.14
Low:26.93
Close:28.74
52wk High:73.35
52wk Low:26.66
Shares:55.88M
Float Shares:53.56M
Volume Ratio:0.87
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5382
EPS(LYR):-1.7537
ROE:-27.22%
ROA:-13.06%
PB:4.29
PE(LYR):-16.66

Loading ...

Procept Biorobotics präsentiert sich auf bedeutenden Gesundheitskonferenzen

Reuters
·
Feb 05

BTIG Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jan 27

Procept Biorobotics Corporation published an update to their financial calendar

Reuters
·
Jan 27

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

GlobeNewswire
·
Jan 27

Assessing PROCEPT BioRobotics (PRCT) Valuation As Fresh Analyst Downgrade Meets Confident Long-Term Growth Views

Simply Wall St.
·
Jan 11

How Investors Are Reacting To PROCEPT BioRobotics (PRCT) UBS Coverage Initiation And 2027 Profitability Outlook

Simply Wall St.
·
Dec 25, 2025

PROCEPT BioRobotics Is Maintained at Buy by Truist Securities

Dow Jones
·
Dec 19, 2025

Truist Securities Adjusts Price Target on PROCEPT BioRobotics to $47 From $50, Maintains Buy Rating

MT Newswires Live
·
Dec 18, 2025

PROCEPT BioRobotics Initiated at Buy by UBS

Dow Jones
·
Dec 13, 2025

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
Dec 09, 2025

PROCEPT BioRobotics has Large Market Opportunity, but Utilization Growth has Slowed, BofA Says

MT Newswires Live
·
Dec 09, 2025

Procept Biorobotics Corp : Bofa Global Research Cuts to Neutral From Buy; Cuts Price Objective to $38 From $55

THOMSON REUTERS
·
Dec 08, 2025

PROCEPT BioRobotics Cut to Neutral From Buy by B of A Securities

Dow Jones
·
Dec 08, 2025

PROCEPT BioRobotics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Dec 03, 2025

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

GlobeNewswire
·
Nov 21, 2025

Procept Biorobotics Showcases Aquablation Therapy as Next-Generation BPH Solution in Investor Presentation

Reuters
·
Nov 11, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: PROCEPT BioRobotics (PRCT), Day One Biopharmaceuticals (DAWN) and Exelixis (EXEL)

TIPRANKS
·
Nov 06, 2025

PROCEPT BioRobotics Price Target Cut to $50.00/Share From $55.00 by Piper Sandler

Dow Jones
·
Nov 06, 2025

Stock Track | PROCEPT BioRobotics Plummets 7.71% as 2026 Revenue Guidance Disappoints Despite Q3 Beat

Stock Track
·
Nov 05, 2025

PROCEPT BioRobotics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025